EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug trial offers hope for kids with tough cancers
Disease control OngoingThis study is testing a new drug called CLR 131 in children and young adults whose cancers have come back or haven't responded to standard treatments. The drug is designed to deliver radiation directly to cancer cells. The main goals are to find a safe dose and see if the drug sh…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat bone cancer in kids and young adults
Disease control OngoingThis study is testing if it's safe to add a drug called regorafenib to the standard, intensive chemotherapy for Ewing sarcoma. It aims to help children and young adults (ages 2-49) whose cancer has spread to multiple parts of the body, a situation with very limited treatment opti…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope pill tested for kids with tough cancers
Disease control OngoingThis study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for kids with tough cancers: scientists test 'Re-Trained' immune cells
Disease control OngoingThis early-stage study is testing a new type of personalized cell therapy for children and young adults whose solid tumors have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cance…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for kids with tough cancers: genetically engineered immune cells target tumors
Disease control OngoingThis early-phase study is testing the safety and feasibility of a new treatment called CAR T-cell therapy for children and young adults whose solid tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to be…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New scan aims to see tumors more clearly
Diagnosis OngoingThis study is testing a new type of imaging scan to see if it can better detect and monitor tumors in children and young adults with cancer. The scan uses a radioactive form of a natural protein building block called methionine. Researchers want to see how well this new scan work…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC